Henry Schein, Inc. (HSIC) has been in the news for several reasons, with evaluations of its fair value and potential undervaluation. The company has completed the acquisition of
Acentus, and this move is expected to positively affect the HSIC stock. The company is also expansively diversifying its portfolio, including entry into the
orthopedic market and the expansion of its
continuous glucose monitor offerings. However, some unease comes from soft returns on capital and a potential over-inflated stock price. Recent earnings reports show mixed results, with a Q3 report topping estimates while also citing recovery from a cyber incident. The company also cut its annual profit forecast due to the lingering impact of a cyberattack. While some insiders sold considerable volumes of stock, activist investors like
Ananym Capital are pushing for changes that could improve profits. In addition to its financial activities, the company is involved in community outreach, such as launching a $300,000 emergency relief fund for Los Angeles wildfires, building hygiene kits for Ronald McDonald House Charities, and opening a customer assistance hotline ahead of Hurricanes Milton and Helene.
Henry Schein HSIC News Analytics from Mon, 11 Oct 2021 07:00:00 GMT to Sat, 18 Jan 2025 09:05:21 GMT -
Rating 1
- Innovation 2
- Information 6
- Rumor -5
